CH

CHEIL BIO CO., LTD.

Develops and manufactures veterinary medicines and functional feed additives.

052670 | KO

Overview

Corporate Details

ISIN(s):
KR7052670007
LEI:
Country:
South Korea
Address:
경기 안산시 목내동 456-2, 안산시

Description

CHEIL BIO CO., LTD. is a company that develops, manufactures, and markets a wide range of advanced veterinary products. The company focuses on improving the health and productivity of livestock through solutions based on extensive research and biotechnology. Its core offerings include animal medicines, such as antibiotics and antimicrobials, and functional feed additives. These products cater to a diverse market, including the swine, poultry, cattle, and aquaculture sectors, as well as companion animals. The company leverages its dedicated research and development capabilities to create high-quality, market-competitive products and aims to achieve global technological competitiveness in the animal health industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
[기재정정]액면주식ㆍ무액면주식전환결정
Korean 16.9 KB
2025-09-15 00:00
[기재정정]주요사항보고서(감자결정)
Korean 31.6 KB
2025-09-10 00:00
주요사항보고서(소송등의제기)
Korean 5.7 KB
2025-08-26 00:00
주권매매거래정지기간변경 (주식의 병합, 분할 등 전자등록 변경, 말소)
Korean 4.9 KB
2025-08-26 00:00
횡령ㆍ배임혐의진행사항
Korean 8.4 KB
2025-08-14 00:00
[기재정정]사업보고서 (2024.12)
Korean 1.0 MB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 780.5 KB
2025-08-14 00:00
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 14.1 KB
2025-08-01 00:00
임시주주총회결과
Korean 14.4 KB
2025-08-01 00:00
[기재정정]액면주식ㆍ무액면주식전환결정
Korean 15.4 KB
2025-08-01 00:00
[기재정정]주요사항보고서(감자결정)
Korean 35.6 KB
2025-07-21 00:00
횡령ㆍ배임혐의진행사항
Korean 6.9 KB
2025-07-18 00:00
[기재정정]주주총회소집결의 (임시주주총회)
Korean 9.6 KB
2025-07-18 00:00
액면주식ㆍ무액면주식전환결정
Korean 10.6 KB
2025-07-18 00:00
주요사항보고서(감자결정)
Korean 24.7 KB

Automate Your Workflow. Get a real-time feed of all CHEIL BIO CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CHEIL BIO CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CHEIL BIO CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.